In a focused exploration, we designed, synthesized, and biologically evaluated chiral conjugated new chloroquine (CQ) analogues with substituted piperazines as antimalarial agents. as well as studies revealed that compound 7c showed potent activity ( 50% inhibitory concentration, 56.98 nM for strain 3D7 and 97.
View Article and Find Full Text PDFA series of short chain 4-aminoquinoline-imidazole derivatives have been synthesized in one pot two step multicomponent reaction using van leusen standard protocol. The diethylamine function of chloroquine is replaced by substituted imidazole derivatives containing tertiary terminal nitrogen. All the synthesized compounds were screened against the chloroquine sensitive (3D7) and chloroquine resistant (K1) strains of Plasmodium falciparum.
View Article and Find Full Text PDFA novel 4-aminoquinoline derivative [()-7-chloro--(4-methyl-1-(4-methylpiperazin-1-yl)pentan-2-yl)-quinolin-4-amine triphosphate] exhibiting curative activity against chloroquine-resistant malaria parasites has been identified for preclinical development as a blood schizonticidal agent. The lead molecule selected after detailed structure-activity relationship (SAR) studies has good solid-state properties and promising activity against and experimental malaria models. The absorption, distribution, metabolism, and excretion (ADME) parameters indicate a favorable drug-like profile.
View Article and Find Full Text PDF